HDL - Cholesterol: The New Target for Treatment

Publisher： Bentham Science Publishers

E-ISSN： 2212-3334|4|2|153-160

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.4, Iss.2, 2010-06, pp. : 153-160

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiac Fat as New Diagnostic Tool and Potential Therapeutic Target for Obesity Management and Treatment

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 1, Iss. 2, 2007-06 ,pp. : 162-165

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammasome as a New Therapeutic Target for Diabetic Complications

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 10, Iss. 1, 2016-10 ,pp. : 56-62

Bentham Science Publishers

Access to resources Recommend Favorite

Molecules to Selectively Target Receptors for Treatment of Pain and Neurogenic Inflammation

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 6, Iss. 1, 2012-01 ,pp. : 35-45

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Patents on PCSK9: A New Target for Treating Hypercholesterolemia

By  

Recent Patents on DNA & Gene Sequences, Vol. 3, Iss. 3, 2009-11 ,pp. : 201-212

Bentham Science Publishers

Access to resources Recommend Favorite

Antileukotriene Treatment in Children with Asthma - New Patents

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 2, Iss. 3, 2008-11 ,pp. : 202-211

Bentham Science Publishers

Access to resources Recommend Favorite